WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical firm devoted to advancing focused protein degradation science, as we speak introduced that C4T administration will take part in a hearth chat on the UBS Focused Protein Degradation (TPD) Day happening nearly on July 15, 2024.
Fireplace Chat Particulars:
Occasion: UBS TPD Day
Date/Time: Monday, July 15, 2024 from 12:00 pm ET “ 12:30 pm ET
A stay webcast will likely be obtainable on the Buyers part of the corporate’s web site at www.c4therapeutics.com. An archived replay of the webcast will likely be obtainable for about 30 days following the stay occasion.
About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical firm devoted to delivering on the promise of focused protein degradation science to create a brand new technology of medicines that transforms sufferers’ lives. C4T is progressing focused oncology packages by means of medical research and leveraging its TORPEDO ® platform to effectively design and optimize small-molecule medicines to handle difficult-to-treat ailments. C4T’s degrader medicines are designed to harness the physique’s pure protein recycling system to quickly degrade disease-causing proteins, providing the potential to beat drug resistance, drug undruggable targets and enhance affected person outcomes. For extra data, please go to www.c4therapeutics.com.
Contacts:
Buyers:
Courtney Solberg
Senior Supervisor, Investor Relations
[email protected]
Media:
Loraine Spreen
Senior Director, Company Communications & Affected person Advocacy
[email protected]